Evotec OAI Signs a Chemical Library Contract with Roche

20-Jun-2001

Evotec OAI, Hamburg, Germany (EVOTEC BioSystems AG, Neuer Markt: EVT) a supplier of high value added biological, chemical and screening services, has signed a one-year contract to supply chemical compound libraries and associated data to Roche, of Basel, Switzerland. The compounds will be used by Roche in their drug discovery screening programmes.

Dr Edwin Moses, President of Evotec OAI, said:

"We are very pleased to have secured this contract with Roche, one of the world's leading research-oriented healthcare companies, to supply libraries to support their screening programmes. We have worked with Roche before on similar projects and look forward to this, enjoyable partnership and are confident that through our expertise in this area we can add significant value to their drug discovery programmes."

Dr Dave Brown, Roche's Global Head of Chemistry and Head of Pre-clinical R&D at Roche, Welwyn, UK, added:

"We're very pleased to be working with Evotec OAI, a company with a well-established reputation as a provider of chemistry and biology services and a good corporate partner. This Alliance extends Roche's commitment to building a world-class compound library for random and focused screening."

Other news from the department

Most read news

More news from our other portals

Discover the latest developments in battery technology!